{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:11:29Z","timestamp":1794100289038,"version":"4.8.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vanderbilt CTSA","award":["R01 AG047992-01A1"],"award-info":[{"award-number":["R01 AG047992-01A1"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes on Aging","award":["R01 AG047992-01A1"],"award-info":[{"award-number":["R01 AG047992-01A1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jagp.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T07:07:05Z","timestamp":1491462425000},"page":"1415-1426","source":"Crossref","is-referenced-by-count":84,"title":["Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults"],"prefix":"10.1016","volume":"25","author":[{"given":"Jennifer N.","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Newhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2017.04.001_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.seminoncol.2011.03.014","article-title":"An update on cancer- and chemotherapy-related cognitive dysfunction: current status","volume":"38","author":"Janelsins","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.me.34.020183.000343","article-title":"Chemotherapy and cognitive defects in cancer patients","volume":"34","author":"Silberfarb","year":"1983","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jagp.2017.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pon.3196","article-title":"Brain vulnerability to chemotherapy toxicities","volume":"21","author":"Ahles","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","article-title":"Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma","volume":"20","author":"Ahles","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/j.seminoncol.2013.09.006","article-title":"Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?","volume":"40","author":"Mandelblatt","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jagp.2017.04.001_bib0040","author":"Colby"},{"key":"10.1016\/j.jagp.2017.04.001_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00520-013-2029-7","article-title":"Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment","volume":"22","author":"Craig","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","article-title":"Chemotherapy-related cognitive dysfunction","volume":"12","author":"Wefel","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jagp.2017.04.001_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jagp.2017.04.001_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3322\/caac.21258","article-title":"Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults","volume":"65","author":"Wefel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jagp.2017.04.001_bib0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S1355617709090316","article-title":"Long-term cognitive function following chemotherapy in patients with testicular cancer","volume":"15","author":"Pedersen","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.jagp.2017.04.001_bib0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/pon.3453","article-title":"A prospective study of cognitive function in men with non-seminomatous germ cell tumors","volume":"23","author":"Wefel","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0075","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1002\/cncr.28323","article-title":"Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant","volume":"119","author":"Jones","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.critrevonc.2007.06.001","article-title":"Cognitive function after chemotherapy in adults with solid tumours","volume":"63","author":"Vardy","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2010.06.023","article-title":"Cognitive functions in long-term survivors of ovarian cancer","volume":"119","author":"Correa","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-12-371","article-title":"Effects of androgen deprivation on brain function in prostate cancer patients\u2014a prospective observational cohort analysis","volume":"12","author":"Chao","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11920-014-0490-8","article-title":"Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments","volume":"16","author":"Vega","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jagp.2017.04.001_bib0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"Ahles","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence, mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jagp.2017.04.001_bib0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jgo.2016.04.008","article-title":"Chemotherapy-related cognitive impairment in older patients with cancer","volume":"7","author":"Loh","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pon.742","article-title":"The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy","volume":"12","author":"Ahles","year":"2003","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cncr.25685","article-title":"Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors","volume":"117","author":"Small","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0125","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.2013.54.2050","article-title":"Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?","volume":"32","author":"Mandelblatt","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0130","author":"Surveillance, Epidemiology, and End Results (SEER) Program"},{"key":"10.1016\/j.jagp.2017.04.001_bib0135","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2007.10.8928","article-title":"Science of cancer and aging","volume":"25","author":"Irminger-Finger","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1474-9726.2009.00475.x","article-title":"Aging and cancer cell biology, 2009","volume":"8","author":"Campisi","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.jagp.2017.04.001_bib0145","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ncb1106-1213","article-title":"ROS as a tumour suppressor?","volume":"8","author":"Ramsey","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566524053586545","article-title":"Telomeres as biomarkers for ageing and age-related diseases","volume":"5","author":"von Zglinicki","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jagp.2017.04.001_bib0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1196\/annals.1354.022","article-title":"Mitochondria damage checkpoint, aging, and cancer","volume":"1067","author":"Singh","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jagp.2017.04.001_bib0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0531-5565(99)00011-X","article-title":"The mitochondrial theory of aging: do damaged mitochondria accumulate by delayed degradation?","volume":"34","author":"Kowald","year":"1999","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mrfmmm.2004.04.001","article-title":"Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer","volume":"554","author":"Blasiak","year":"2004","journal-title":"Mutat Res"},{"key":"10.1016\/j.jagp.2017.04.001_bib0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2005.07.025","article-title":"DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy","volume":"239","author":"Nadin","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jagp.2017.04.001_bib0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mehy.2006.01.045","article-title":"Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?","volume":"67","author":"Maccormick","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jagp.2017.04.001_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjc.6600347","article-title":"Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes","volume":"87","author":"Tsavaris","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cyto.2003.10.004","article-title":"Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy","volume":"25","author":"Pusztai","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.jagp.2017.04.001_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1525-1438.2000.00003.x","article-title":"Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel","volume":"10","author":"Penson","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0200","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1158\/1078-0432.CCR-05-2398","article-title":"Inflammatory biomarkers for persistent fatigue in breast cancer survivors","volume":"12","author":"Collado-Hidalgo","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jagp.2017.04.001_bib0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosom Med"},{"issue":"suppl","key":"10.1016\/j.jagp.2017.04.001_bib0210","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.bbi.2012.07.015","article-title":"Does tumor necrosis factor-alpha (TNF-\u03b1) play a role in post-chemotherapy cerebral dysfunction?","volume":"30","author":"Ganz","year":"2013","journal-title":"Brain Behav Immun"},{"issue":"suppl","key":"10.1016\/j.jagp.2017.04.001_bib0215","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","article-title":"Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors","volume":"30","author":"Kesler","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jagp.2017.04.001_bib0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0027-5107(02)00313-5","article-title":"Changes in the human mitochondrial genome after treatment of malignant disease","volume":"525","author":"Wardell","year":"2003","journal-title":"Mutat Res"},{"key":"10.1016\/j.jagp.2017.04.001_bib0225","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1054\/bjoc.2001.1803","article-title":"Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation","volume":"84","author":"Schr\u00f6der","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0230","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000173649.99261.DF","article-title":"Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation","volume":"80","author":"Lahav","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jagp.2017.04.001_bib0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neurobiolaging.2004.07.016","article-title":"Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients","volume":"26","author":"Migliore","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2017.04.001_bib0240","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","article-title":"Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview","volume":"827","author":"Mariani","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jagp.2017.04.001_bib0250","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2741\/1562","article-title":"Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior","volume":"10","author":"Tonelli","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.jagp.2017.04.001_bib0255","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","article-title":"Inflammatory markers and the risk of Alzheimer disease: the Framingham Study","volume":"68","author":"Tan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0260","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jagp.2017.04.001_bib0265","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","article-title":"Cancer- and cancer treatment-associated cognitive change: an update on the state of the science","volume":"30","author":"Ahles","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.jagp.2017.04.001_bib0270","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","article-title":"Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study","volume":"30","author":"McDonald","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jagp.2017.04.001_bib0275","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2011.38.5674","article-title":"Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study","volume":"30","author":"McDonald","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-010-1088-4","article-title":"Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study","volume":"123","author":"McDonald","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jagp.2017.04.001_bib0285","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10549-011-1888-1","article-title":"Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy","volume":"132","author":"Koppelmans","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jagp.2017.04.001_bib0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","article-title":"Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310 years after chemotherapy","volume":"103","author":"Silverman","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jagp.2017.04.001_bib0295","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1200\/JCO.2009.27.0827","article-title":"Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve","volume":"28","author":"Ahles","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0300","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.2008.21.3553","article-title":"Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial","volume":"28","author":"Schilder","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0305","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.55.1259","article-title":"Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors","volume":"32","author":"Mandelblatt","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WAD.0000000000000086","article-title":"Cancer and dementia: it's complicated","volume":"29","author":"Ganguli","year":"2015","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2017.04.001_bib0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/COC.0b013e3181b9cf1b","article-title":"Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort","volume":"33","author":"Du","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jagp.2017.04.001_bib0325","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.20393","article-title":"Chemobrain\u201d in breast carcinoma?: a prologue","volume":"101","author":"Wefel","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0330","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ejca.2014.05.026","article-title":"Baseline cognitive functions among elderly patients with localised breast cancer","volume":"50","author":"Lange","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0335","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0340","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1200\/JCO.2007.10.8639","article-title":"Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy","volume":"25","author":"Ferguson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0345","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1158\/1078-0432.CCR-09-1227","article-title":"Regional brain activation during verbal declarative memory in metastatic breast cancer","volume":"15","author":"Kesler","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jagp.2017.04.001_bib0350","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2011.245","article-title":"Prefrontal cortex and executive function impairments in primary breast cancer","volume":"68","author":"Kesler","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0355","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13670-016-0182-9","article-title":"Cognition and cognitive impairment in older adults with cancer","volume":"5","author":"Magnuson","year":"2016","journal-title":"Curr Geriatr Rep"},{"key":"10.1016\/j.jagp.2017.04.001_bib0360","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1532-5415.2004.52461.x","article-title":"Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia","volume":"52","author":"Gupta","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2017.04.001_bib0365","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1532-5415.2005.00467.x","article-title":"Treatment for breast cancer in patients with Alzheimer's disease","volume":"53","author":"Gorin","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2017.04.001_bib0370","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.168.18.2033","article-title":"Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer","volume":"168","author":"Raji","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2017.04.001_bib0375","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0380","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0385","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1470-2045(08)70207-9","article-title":"Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II)","volume":"9","author":"Jenkins","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0390","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pon.964","article-title":"Cognitive impairment associated with adjuvant therapy in breast cancer","volume":"15","author":"Bender","year":"2006","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0395","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pon.1453","article-title":"Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study","volume":"18","author":"Collins","year":"2009","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0400","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/02841860802314738","article-title":"Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study","volume":"48","author":"Schilder","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0405","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11764-008-0070-1","article-title":"Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls","volume":"2","author":"Palmer","year":"2008","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jagp.2017.04.001_bib0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1006426132338","article-title":"Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen","volume":"64","author":"Paganini-Hill","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jagp.2017.04.001_bib0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pon.709","article-title":"Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study","volume":"13","author":"Jenkins","year":"2004","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0420","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/gme.0b013e318148b28b","article-title":"Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer","volume":"14","author":"Bender","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.jagp.2017.04.001_bib0425","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0430","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2017.04.001_bib0435","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2017.04.001_bib0440","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pon.3608","article-title":"Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison","volume":"24","author":"Lee","year":"2015","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0445","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/annonc\/mdr447","article-title":"Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy","volume":"23","author":"Storey","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0450","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","article-title":"Testosterone levels and cognition in elderly men: a review","volume":"69","author":"Holland","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.jagp.2017.04.001_bib0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jagp.2017.04.001_bib0460","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jagp.2017.04.001_bib0465","first-page":"135","article-title":"Heart disease as a risk factor for dementia","volume":"5","author":"Justin","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0470","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1200\/JCO.2014.60.1963","article-title":"Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison","volume":"33","author":"Gonzalez","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00520-009-0625-3","article-title":"Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison","volume":"18","author":"Jim","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0480","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.juro.2006.07.151","article-title":"Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer","volume":"176","author":"Joly","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0485","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1200\/JCO.2010.30.8742","article-title":"Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer","volume":"28","author":"Alibhai","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0490","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00520-014-2285-1","article-title":"Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"22","author":"McGinty","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jamaoncol.2016.3662","article-title":"Association between androgen deprivation therapy and risk of dementia","volume":"3","author":"Nead","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0500","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2407-14-219","article-title":"Impairment of cognitive functioning during sunitinib or sorafenib treatment in cancer patients: a cross sectional study","volume":"14","author":"Mulder","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0505","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/annonc\/mdm455","article-title":"Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy","volume":"18","author":"van der Veldt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.expneurol.2016.06.004","article-title":"The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries","volume":"283","author":"Abdel-Aziz","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0515","article-title":"Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer","author":"Joly","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.jagp.2017.04.001_bib0520","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jpainsymman.2015.06.019","article-title":"Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since 2012","volume":"50","author":"Joly","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jagp.2017.04.001_bib0525","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pon.1133","article-title":"Cognitive-behavioral management of chemotherapy-related cognitive change","volume":"16","author":"Ferguson","year":"2007","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0530","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pon.1878","article-title":"Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial","volume":"21","author":"Ferguson","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0535","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clbc.2013.02.004","article-title":"Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors","volume":"13","author":"Kesler","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1534735415617021","article-title":"YOCAS yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep","volume":"15","author":"Janelsins","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.jagp.2017.04.001_bib0545","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jpainsymman.2009.03.011","article-title":"Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial","volume":"38","author":"Lower","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jagp.2017.04.001_bib0550","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00520-007-0341-9","article-title":"A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer","volume":"16","author":"Mar Fan","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0555","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/cncr.24287","article-title":"The effect of modafinil on cognitive function in breast cancer survivors","volume":"115","author":"Kohli","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0560","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0269216309106872","article-title":"Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial","volume":"23","author":"Lundorff","year":"2009","journal-title":"Palliat Med"},{"issue":"suppl 3","key":"10.1016\/j.jagp.2017.04.001_bib0565","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.3816\/CBC.2002.s.022","article-title":"Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy","volume":"3","author":"O'Shaughnessy","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0570","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/pon.1372","article-title":"The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer","volume":"18","author":"Fan","year":"2009","journal-title":"Psychooncology"},{"key":"10.1016\/j.jagp.2017.04.001_bib0575","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2005.03.3001","article-title":"Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life","volume":"24","author":"Shaw","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0580","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/pbc.24078","article-title":"Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study","volume":"59","author":"Castellino","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jagp.2017.04.001_bib0585","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11764-015-0463-x","article-title":"A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy","volume":"10","author":"Lawrence","year":"2016","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jagp.2017.04.001_bib0590","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1983.03330300035030","article-title":"The prevalence of psychiatric disorders among cancer patients","volume":"249","author":"Derogatis","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2017.04.001_bib0595","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2354.2001.00290.x","article-title":"Depression in palliative care patients\u2014a prospective study","volume":"10","author":"Lloyd-Williams","year":"2001","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jagp.2017.04.001_bib0600","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fpsyg.2012.00489","article-title":"Cognitive and neural aspects of information processing in major depressive disorder: an integrative perspective","volume":"3","author":"Foland-Ross","year":"2012","journal-title":"Front Psychol"},{"key":"10.1016\/j.jagp.2017.04.001_bib0605","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2017.04.001_bib0610","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/gps.2459","article-title":"Broad spectrum assessment of psychopathology and adaptive functioning with the Older Adult Behavior Checklist: a validation and diagnostic discrimination study","volume":"25","author":"Brigidi","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2017.04.001_bib0615","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpainsymman.2006.06.011","article-title":"Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients","volume":"33","author":"Jacobs","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jagp.2017.04.001_bib0620","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jpainsymman.2013.05.010","article-title":"Prospective longitudinal evaluation of a symptom cluster in breast cancer","volume":"47","author":"Sanford","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jagp.2017.04.001_bib0625","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jpainsymman.2008.07.012","article-title":"Evaluating the dimensionality of perceived cognitive function","volume":"37","author":"Lai","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jagp.2017.04.001_bib0630","first-page":"W32","article-title":"Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy-Cognitive Function instrument","volume":"7","author":"Wagner","year":"2009","journal-title":"J Support Oncol"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748117302786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748117302786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T07:33:47Z","timestamp":1658907227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748117302786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":125,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1064748117302786"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2017.04.001","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}